Entrada Therapeutics is finally able to get its Duchenne muscular dystrophy candidate (DMD) back on track after the FDA ...

Receives FDA authorization to initiate ELEVATE-44-102, a Phase 1b multiple ascending dose clinical study of ENTR-601-44 in adults living with Duchenne muscular dystrophy – – Follows recently received ...

Entrada Therapeutics gains FDA clearance for its Phase 1b ELEVATE-44-102 study, evaluating ENTR-601-44 in adult Duchenne ...

In a report released today, Boobalan Pachaiyappan from Roth MKM reiterated a Buy rating on Entrada Therapeutics Inc (TRDA – Research Report), ...

Entrada Therapeutics (TRDA) announced that the United States Food and Drug Administration has lifted the clinical hold on ENTR-601-44 and ...

Shares of Entrada Therapeutics rose after regulators removed a clinical hold and said its lead product candidate could be studied as a treatment for Duchenne muscular dystrophy. The stock was up 9.5% ...

Receives FDA authorization to initiate ELEVATE-44-102, a Phase 1b multiple ascending dose clinical study of ENTR-601-44 in adults living with Duchenne muscular dystrophy - - Follows recently received ...

New rivalries, fresh faces, line-up changes and much more. Gear up for Buriram as MotoGP blasts back into action ...

Providing expert witness testimony and detailed reports to assist in legal cases. Forensic engineering is a critical ...

In the complex world of forensic engineering, Appraisals & Arbitration play a fundamental role in resolving disputes and ...

Interested parties may access the live and archived webcasts under the "Investors” section of the company's website at: https ...

The 15-year-old festival will be held Feb. 27 through March 1 at Megaplex Theatres Sunset in St. George at 8:30 p.m.